# The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.

> **NCT04513119** · — · UNKNOWN · sponsor: **Southwest Hospital, China** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Carcinoma Stage I
- Radiofrequency Ablation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04513119
- **Lead sponsor:** Southwest Hospital, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513119, "The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04513119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*